WSFS
CRNX icon

Wilmington Savings Fund Society’s Crinetics Pharmaceuticals CRNX Stock Holding History

Wilmington Savings Fund Society’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20
Closed -$575 – 1522
2025
Q2 		$575 Hold
20
– – ﹤0.01% 1989
2025
Q1 		$671 Hold
20
– – ﹤0.01% 2005
2024
Q4 		$1.02K Hold
20
– – ﹤0.01% 2001
2024
Q3 		$1.02K Buy
+20
New +$1.03K ﹤0.01% 1981

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Wilmington Savings Fund Society's CRNX Position: Q3 2025 in Review

Wilmington Savings Fund Society sold out of Crinetics Pharmaceuticals (CRNX) in Q3 2025, closing a stake of 20 shares — an estimated $575 sold.

Wilmington Savings Fund Society first reported a position in CRNX in Q3 2024 and held it in 4 quarters. The position peaked at $1.02K in Q4 2024. 225 funds tracked by Wall St. Rank hold CRNX as of Q3 2025.

  • Wilmington Savings Fund Society reported no remaining Crinetics Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Wilmington Savings Fund Society sold 20 Crinetics Pharmaceuticals shares in Q3 2025, an estimated $575.
  • Wilmington Savings Fund Society first reported a position in Crinetics Pharmaceuticals in Q3 2024 and held it in 4 quarters.
  • Wilmington Savings Fund Society's Crinetics Pharmaceuticals position peaked at $1.02K in Q4 2024.
  • 225 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q3 2025.

Based on Wilmington Savings Fund Society's 13F filing for Q3 2025, filed 28 Oct 2025.